comparemela.com

Latest Breaking News On - Biosciences holdings inc - Page 1 : comparemela.com

Harmony's Q1 Report Shows Growth in Sleep/Wake Portfolio

Harmony Biosciences Holdings Inc reported first-quarter results, showcasing progress in its sleep/wake portfolio.

Jeffreym-dayno
Drug-administration
Harmony-biosciences-holdings-inc
Biosciences-holdings-inc
Wake-highlights
Drug-user-fee-act
Prescription-drug-user-fee-act
Prader-willi-syndrome

Harmony Secures Rights to Develop Bioprojet's Orexin-2 Agonist

Harmony has entered into a licensing agreement to develop and commercialize TPM-1116, a selective oral orexin-2 receptor agonist.

France
United-states
American
French
America
Jean-charles-schwartz
Jeffreym-dayno
Harmony-biosciences-holdings-inc
Harmony-biosciences
Latin-american
Biosciences-holdings-inc
European-academies

Phase 3 Study of Pitolisant for Prader-Willi Syndrome Begins

The study will evaluate pitolisant for treating excessive daytime sleepiness and behavioral symptoms in patients with Prader-Willi syndrome.

Kumar-budur
Harmony-biosciences-holdings-inc
Drug-administration
Biosciences-holdings-inc
Orphan-drug
Harmony-biosciences

Evaluating Harmony Biosciences: Insights From 8 Financial Analysts - Harmony Biosciences (NASDAQ:HRMY)

Health-care
Harmony-biosciences-holdings-inc
Down-analyst-ratings
Harmony-biosciences
Know-about-harmony
Biosciences-holdings-inc
Revenue-trend
Examining-harmony-biosciences

North American Morning Briefing : Nvidia Ignites -2- - 2024-02-22

Teck Declares Dividend of 12.5c; Board Authorized Up to $500M Share Buyback; Planned Repurchase Reflect Distribution in Respect of 30% of Proceeds From Minority Sale of Steelmaking-Coal Business to. -February 22, 2024 at 06:20 am EST - MarketScreener

Japan
Germany
Denbury
Devon
United-kingdom
France
Nippon
Gordon-haskett
Piper-sandler
Weekly-international
Armada-hoffler-properties
Palo-alto-networks-cut-to-neutral-from

vimarsana © 2020. All Rights Reserved.